These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 8294427)
1. Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR. Draeger LJ; Mullen GP J Biol Chem; 1994 Jan; 269(3):1785-93. PubMed ID: 8294427 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Giorello L; Clerico L; Pescarolo MP; Vikhanskaya F; Salmona M; Colella G; Bruno S; Mancuso T; Bagnasco L; Russo P; Parodi S Cancer Res; 1998 Aug; 58(16):3654-9. PubMed ID: 9721875 [TBL] [Abstract][Full Text] [Related]
3. Preferential heterodimeric parallel coiled-coil formation by synthetic Max and c-Myc leucine zippers: a description of putative electrostatic interactions responsible for the specificity of heterodimerization. Lavigne P; Kondejewski LH; Houston ME; Sönnichsen FD; Lix B; Skyes BD; Hodges RS; Kay CM J Mol Biol; 1995 Dec; 254(3):505-20. PubMed ID: 7490766 [TBL] [Abstract][Full Text] [Related]
4. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems. Pescarolo MP; Bagnasco L; Malacarne D; Melchiori A; Valente P; Millo E; Bruno S; Basso S; Parodi S FASEB J; 2001 Jan; 15(1):31-33. PubMed ID: 11099487 [TBL] [Abstract][Full Text] [Related]
5. Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc. Nieddu E; Melchiori A; Pescarolo MP; Bagnasco L; Biasotti B; Licheri B; Malacarne D; Tortolina L; Castagnino N; Pasa S; Cimoli G; Avignolo C; Ponassi R; Balbi C; Patrone E; D'arrigo C; Barboro P; Vasile F; Orecchia P; Carnemolla B; Damonte G; Millo E; Palomba D; Fassina G; Mazzei M; Parodi S FASEB J; 2005 Apr; 19(6):632-4. PubMed ID: 15671156 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions. Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223 [TBL] [Abstract][Full Text] [Related]
7. Design and properties of a Myc derivative that efficiently homodimerizes. Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157 [TBL] [Abstract][Full Text] [Related]
8. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Blackwood EM; Eisenman RN Science; 1991 Mar; 251(4998):1211-7. PubMed ID: 2006410 [TBL] [Abstract][Full Text] [Related]
9. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers. Muhle-Goll C; Nilges M; Pastore A Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944 [TBL] [Abstract][Full Text] [Related]
10. Determination of the DNA sequence recognized by the bHLH-zip domain of the N-Myc protein. Alex R; Sözeri O; Meyer S; Dildrop R Nucleic Acids Res; 1992 May; 20(9):2257-63. PubMed ID: 1594445 [TBL] [Abstract][Full Text] [Related]
11. Structural constraints for DNA recognition by Myc and other b-HLH-ZIP proteins: design of oncoprotein analogues. Takemoto C; Fisher DE Gene Expr; 1995; 4(6):311-7. PubMed ID: 7549463 [TBL] [Abstract][Full Text] [Related]
12. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024 [TBL] [Abstract][Full Text] [Related]
13. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Solomon DL; Amati B; Land H Nucleic Acids Res; 1993 Nov; 21(23):5372-6. PubMed ID: 8265351 [TBL] [Abstract][Full Text] [Related]
14. The dimerization stability of the HLH-LZ transcription protein family is modulated by the leucine zippers: a CD and NMR study of TFEB and c-Myc. Muhle-Goll C; Gibson T; Schuck P; Schubert D; Nalis D; Nilges M; Pastore A Biochemistry; 1994 Sep; 33(37):11296-306. PubMed ID: 7727380 [TBL] [Abstract][Full Text] [Related]
15. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc. Gupta K; Anand G; Yin X; Grove L; Prochownik EV Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857 [TBL] [Abstract][Full Text] [Related]
16. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation. Arsura M; Deshpande A; Hann SR; Sonenshein GE Mol Cell Biol; 1995 Dec; 15(12):6702-9. PubMed ID: 8524235 [TBL] [Abstract][Full Text] [Related]
17. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper. Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483 [TBL] [Abstract][Full Text] [Related]
18. Sequence-specific DNA binding by the c-Myc protein. Blackwell TK; Kretzner L; Blackwood EM; Eisenman RN; Weintraub H Science; 1990 Nov; 250(4984):1149-51. PubMed ID: 2251503 [TBL] [Abstract][Full Text] [Related]
19. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding. Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448 [TBL] [Abstract][Full Text] [Related]
20. DNA binding by N- and L-Myc proteins. Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]